Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    suvorexant
Show Display Options
RSS Create an RSS feed from your search for:
suvorexant
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)
Conditions: Insomnia;   Hepatic Insufficiency
Intervention: Drug: Suvorexant
2 Recruiting Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)
Conditions: Insomnia;   Alzheimer's Disease
Interventions: Drug: Suvorexant 10 mg;   Drug: Suvorexant 20 mg;   Drug: Placebo
3 Recruiting A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
Condition: Insomnia
Interventions: Drug: Suvorexant;   Drug: Placebo
4 Not yet recruiting To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia
Conditions: Hypertension;   Insomnia
Interventions: Drug: suvorexant;   Other: Placebo
5 Recruiting Suvorexant in Insomnia Co-morbid With Fibromyalgia
Conditions: Insomnia;   Fibromyalgia
Interventions: Drug: suvorexant;   Drug: placebo
6 Completed
Has Results
Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)
Condition: Insomnia
Interventions: Drug: suvorexant;   Drug: Placebo
7 Completed
Has Results
Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
Condition: Insomnia
Intervention: Drug: Suvorexant
8 Recruiting Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder
Conditions: Insomnia;   Bipolar Disorder
Interventions: Drug: Suvorexant;   Drug: Placebo
9 Completed
Has Results
A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)
Condition: Insomnia
Interventions: Drug: Suvorexant;   Drug: Dose-matched Placebo to Suvorexant
10 Completed
Has Results
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant High Dose (HD);   Drug: Suvorexant Low Dose (LD);   Drug: Comparator: Placebo
11 Recruiting Suvorexant and Trauma Related Insomnia
Conditions: Insomnia;   Posttraumatic Stress Disorder
Interventions: Drug: suvorexant;   Other: placebo
12 Completed
Has Results
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant High Dose (HD);   Drug: Suvorexant Low Dose (LD);   Drug: Comparator: Placebo
13 Not yet recruiting A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
Conditions: Depression;   Major Depressive Disorder;   MDD;   Insomnia
Interventions: Drug: suvorexant;   Drug: Placebo
14 Completed
Has Results
Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036)
Condition: Sleep Apnea
Interventions: Drug: Suvorexant;   Drug: Matching Placebo
15 Completed
Has Results
Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant;   Drug: Dose-matched Placebo to Suvorexant
16 Not yet recruiting Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder
Condition: Posttraumatic Stress Disorder
Interventions: Drug: suvorexant;   Other: placebo
17 Recruiting Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers
Condition: Sleep Disorder, Shift-Work
Interventions: Drug: Suvorexant;   Drug: Placebo
18 Recruiting Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use
Conditions: Cocaine Use Disorder;   Anxiety
Interventions: Drug: suvorexant;   Drug: Placebo (for suvorexant)
19 Completed A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)
Condition: Insomnia
Interventions: Drug: MK-4305 40 mg;   Drug: MK-4305 20 mg;   Drug: Zopiclone;   Drug: Grossly Matching Placebo for Zopiclone;   Drug: Matching Placebo for MK-4305
20 Recruiting The Role of Orexin in Human Panic Disorder
Condition: Panic Disorder
Interventions: Drug: suvorexant;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.